Dupilumab treatment for allergic bronchopulmonary aspergillosis: A case series

J Allergy Clin Immunol Pract. 2020 Feb;8(2):742-743. doi: 10.1016/j.jaip.2019.11.031. Epub 2019 Dec 4.

Authors

Richard Paul Ramonell¹, F Eun-Hyung Lee¹, Colin Swenson¹, Merin Kuruvilla²

Affiliations

¹ Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, Ga.
² Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, Ga. Electronic address: merin.kuruvilla@emoryhealthcare.org.

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized
Aspergillosis, Allergic Bronchopulmonary* / drug therapy
Humans
Itraconazole

Substances

Antibodies, Monoclonal, Humanized
Itraconazole
dupilumab

Grants and funding

T32 HL116271/HL/NHLBI NIH HHS/United States